# NCT01516216 (NCT01516216)

> Study of Vitamin D in Untreated Metastatic Colorectal Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01516216
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Dana-Farber Cancer Institute
- Conditions: Metastatic Colorectal Cancer
- Interventions: FOLFOX + bevacizumab; Vitamin D
- Enrollment: 139
- Primary outcome: Median Progression-free Survival (PFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 124

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct01516216

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01516216", "email": "<work email>"}; the inbox owner confirms by the emailed link.